Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,975,346
+$9,504,628 QoQ
Shares Held
208,589
+17.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#431
of 4,664 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vident Advisory, LLC holds $305,361,582 across 15 Drug Manufacturers - General names. JNJ ranks #2 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
70,087 | $84,064,454 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
208,589 | $52,975,346 | |
| 3 | ABBV |
AbbVie Inc.
|
188,691 | $47,482,201 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
225,823 | $28,530,472 | |
| 5 | MRK |
Merck & Co., Inc.
|
175,764 | $22,585,673 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
242,261 | $13,959,076 | |
| 7 | AMGN |
Amgen Inc
|
37,277 | $13,498,744 | |
| 8 | SNY |
Sanofi
|
302,447 | $12,902,388 |
All Filings in JNJ
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,975,346 | 208,589 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $43,470,718 | 177,838 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,771,720 | 172,852 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $30,299,666 | 163,411 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,293,054 | 159,038 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,571,681 | 148,165 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $20,578,700 | 142,295 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $18,679,035 | 115,260 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,168,710 | 124,307 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $61,237,878 | 387,116 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $45,743,627 | 291,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $39,797,863 | 255,524 | Shares | Defined | 2024-02-21 | |
| No filing history on record for this holder in this stock. | ||||||